11![Immunological Engineering Immunological Engineering represents a key strategy for dissecting and manipulating molecular processes and for development of proteins for diagnostics and therapeutic intervention. Our research Immunological Engineering Immunological Engineering represents a key strategy for dissecting and manipulating molecular processes and for development of proteins for diagnostics and therapeutic intervention. Our research](https://www.pdfsearch.io/img/56438986dd3677ab1d2877c74755be94.jpg) | Add to Reading ListSource URL: eng.au.dkLanguage: English - Date: 2015-02-02 10:36:26
|
---|
12![Microsoft Word - GL-Immunogenicity assessment of therapeutic proteins Microsoft Word - GL-Immunogenicity assessment of therapeutic proteins](https://www.pdfsearch.io/img/73cda5143a031abf2772d2760f155be4.jpg) | Add to Reading ListSource URL: www.ema.europa.euLanguage: English - Date: 2013-07-21 04:57:48
|
---|
13![CALYPSO BIOTECH SA One line pitch: We develop therapeutic antibodies for severe gastrointestinal diseases Market Analysis: CALYprogram: IBD is a large market with important competition, but with good opportunities CALYPSO BIOTECH SA One line pitch: We develop therapeutic antibodies for severe gastrointestinal diseases Market Analysis: CALYprogram: IBD is a large market with important competition, but with good opportunities](https://www.pdfsearch.io/img/cab6ff7ded3d6d3c29be7ce3e654a540.jpg) | Add to Reading ListSource URL: www.biovision.orgLanguage: English - Date: 2015-03-26 10:58:27
|
---|
14![R&D BioProducts and American Peptide Company Partner to Develop Novel TRAF-6 Peptide Peptide offers significant therapeutic potential to researchers investigating ubiquitin-related neurodegenerative disorders (Greeley, C R&D BioProducts and American Peptide Company Partner to Develop Novel TRAF-6 Peptide Peptide offers significant therapeutic potential to researchers investigating ubiquitin-related neurodegenerative disorders (Greeley, C](https://www.pdfsearch.io/img/778615ad98634e3aeed3811208d495b3.jpg) | Add to Reading ListSource URL: www.americanpeptide.comLanguage: English - Date: 2008-05-15 12:25:20
|
---|
15![Engineering Next-Generation Therapeutic Proteins: Trends and Markets toExecutive Summary Executive Summary Engineering Next-Generation Therapeutic Proteins: Trends and Markets toExecutive Summary Executive Summary](https://www.pdfsearch.io/img/7c7e43d98cfdc1a1dd0d54f9717f6c34.jpg) | Add to Reading ListSource URL: www.insightpharmareports.comLanguage: English - Date: 2011-08-03 14:46:23
|
---|
16![COMMENTARY Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes Is It a Solution? Lucienne Chatenoud COMMENTARY Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes Is It a Solution? Lucienne Chatenoud](https://www.pdfsearch.io/img/f1a4c61e3b54469f6de78d458d09426f.jpg) | Add to Reading ListSource URL: diabetes.diabetesjournals.orgLanguage: English |
---|
17![Therapeutic Antibody Drugs Being Designed for Self-Administration as Developers Seek Competitive Advantage Date: [removed]:17 PM CET Category: Health & Medicine Press release from: Greystone Research Associates Therapeutic Antibody Drugs Being Designed for Self-Administration as Developers Seek Competitive Advantage Date: [removed]:17 PM CET Category: Health & Medicine Press release from: Greystone Research Associates](https://www.pdfsearch.io/img/4d18fc9dccc73845c825301c432d355a.jpg) | Add to Reading ListSource URL: www.openpr.comLanguage: English |
---|
18![Selexis SA to Partner and Exhibit at BIO 2013 Selexis to Meet with Companies Interested in Protein Drug Discovery, Cell Line Development and Lead Identification for Therapeutic Drug Development and Manufacturing. Geneva, Selexis SA to Partner and Exhibit at BIO 2013 Selexis to Meet with Companies Interested in Protein Drug Discovery, Cell Line Development and Lead Identification for Therapeutic Drug Development and Manufacturing. Geneva,](https://www.pdfsearch.io/img/17a88d38ce5b201f2a02ea1980bbbc3b.jpg) | Add to Reading ListSource URL: www.prweb.comLanguage: English - Date: 2013-04-10 08:01:14
|
---|
19![Toxicologist, Therapeutic Antibody Development Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibod Toxicologist, Therapeutic Antibody Development Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibod](https://www.pdfsearch.io/img/8681a592232a9424a611ec745c24f754.jpg) | Add to Reading ListSource URL: www.zymeworks.comLanguage: English - Date: 2015-01-09 00:39:48
|
---|
20![Director, Therapeutic Antibody Discovery Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibody drug Director, Therapeutic Antibody Discovery Zymeworks is a fast-growing biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibody drug](https://www.pdfsearch.io/img/3d52d66be4a0d54b20f6ab335d66437f.jpg) | Add to Reading ListSource URL: www.zymeworks.comLanguage: English - Date: 2014-12-19 13:10:21
|
---|